Literature DB >> 22759732

Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes.

Sabine Fiechter1, André Skaria, Helga Nievergelt, Romain Anex, Luca Borradori, Laurent Parmentier.   

Abstract

BACKGROUND: Photodynamic therapy (PDT) is an established treatment for basal cell carcinomas (BCCs). Although recurrences are sometime observed, their histological patterns have never been specifically studied or compared with the one of the initial tumor.
OBJECTIVE: To compare the histopathological aggressiveness of BCCs recurring after PDT with that of the primary tumors.
METHODS: The study population included 12 patients with 16 post PDT recurrent BCCs. Outcome measures were proportion of histologically aggressive subtypes in BCC recurrences vs. primary tumor.
RESULTS: 62.5% of recurrent BCCs displayed a transition from a non-aggressive to an aggressive subtype.
CONCLUSIONS: Post PDT recurrences appear to display an increased histological aggressiveness, although the latter may reflect the natural course of tumor progression. Despite the presence of potential biases, our study raises the possibility that PDT favors the selection of more aggressive tumor cells. Better systematic large-scale follow-up studies are required to assess the exact frequency and histological types of BCC recurrences after PDT.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22759732     DOI: 10.1159/000339335

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  5 in total

1.  Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy.

Authors:  Yolanda Gilaberte; Laura Milla; Nerea Salazar; Jesús Vera-Alvarez; Omar Kourani; Alejandra Damian; Viviana Rivarola; Maria José Roca; Jesús Espada; Salvador González; Angeles Juarranz
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

Review 2.  Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma.

Authors:  Paola Savoia; Tommaso Deboli; Alberto Previgliano; Paolo Broganelli
Journal:  Int J Mol Sci       Date:  2015-09-28       Impact factor: 5.923

Review 3.  Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.

Authors:  Silvia Rocío Lucena; Nerea Salazar; Tamara Gracia-Cazaña; Alicia Zamarrón; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

Review 4.  Photodynamic Therapy and Non-Melanoma Skin Cancer.

Authors:  Liezel L Griffin; John T Lear
Journal:  Cancers (Basel)       Date:  2016-10-22       Impact factor: 6.639

5.  Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.

Authors:  Tamara Gracia-Cazaña; Marta Mascaraque; Silvia Rocío Lucena; Jesús Vera-Álvarez; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.